This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Healthcare Companies: ICU Medical (ICUI) and GRAIL Inc (GRAL)

Tipranks - Tipranks - Thu May 28, 5:16AM CDT

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on ICU Medical (ICUI) and GRAIL Inc (GRAL) with bullish sentiments.

Memorial Day Sale – Claim 70% Off TipRanks

ICU Medical (ICUI)

In a report released today, Michael Matson from Needham upgraded ICU Medical to Buy, with a price target of $165.00. The company’s shares closed last Tuesday at $134.97.

According to TipRanks.com, Matson is a 3-star analyst with an average return of 1.9% and a 45.3% success rate. Matson covers the Healthcare sector, focusing on stocks such as Insight Molecular Diagnostics, Establishment Labs Holdings, and Zimmer Biomet Holdings. ;'>

Currently, the analyst consensus on ICU Medical is a Strong Buy with an average price target of $164.00.

See Insiders’ Hot Stocks on TipRanks >>

GRAIL Inc (GRAL)

In a report released today, Daniel Brennan from TD Cowen maintained a Buy rating on GRAIL Inc. The company’s shares closed last Tuesday at $68.96.

According to TipRanks.com, Brennan is a 5-star analyst with an average return of 14.1% and a 47.6% success rate. Brennan covers the Healthcare sector, focusing on stocks such as Caris Life Sciences, Inc., Adaptive Biotechnologies, and Tempus AI, Inc. Class A. ;'>

GRAIL Inc has an analyst consensus of Moderate Buy, with a price target consensus of $66.71.

Read More on ICUI:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).